Analyst Price Targets — ALPN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 11, 2024 8:10 am | Robert Driscoll | Wedbush | $65.00 | $47.04 | TheFly | Wedbush downgrades Alpine Immune, sees takeout deal closing |
| April 11, 2024 12:12 am | Michael Ulz | Morgan Stanley | $65.00 | $47.04 | TheFly | Alpine Immune Sciences downgraded to Equal Weight at Morgan Stanley |
| April 9, 2024 6:17 am | Vamil Divan | Guggenheim | $55.00 | $38.53 | TheFly | Alpine Immune Sciences initiated with a Buy at Guggenheim |
| March 20, 2024 4:12 am | Andy Chen | Wolfe Research | $46.00 | $40.23 | StreetInsider | Alpine Immune Sciences (ALPN) PT Raised to $46 at Wolfe Research |
| March 19, 2024 7:45 am | Justin Kim | Oppenheimer | $44.00 | $39.95 | StreetInsider | Alpine Immune Sciences (ALPN) PT Raised to $44 at Oppenheimer |
No recent news available for ALPN.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ALPN.
U.S. House Trading
No House trades found for ALPN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.